For investors seeking a reliable, income-generating asset, Centurion Accommodation REIT (CAREIT) is worth attention.

Listed on the SGX in Sept 2025, the REIT's just-released 1H2026 results have comfortably outperformed its IPO prospectus forecasts.

More importantly, management is signalling that the earnings momentum has not yet run its course.
 

When it comes to REITs, three key numbers matter a lot: Revenue, Net Property Income (NPI - what is left after paying property bills), and Distribution per Unit (DPU - the cash payout you receive).

CAREIT delivered a good performance across all three:

  • Gross Revenue hit S$108.9 million, beating the prospectus forecast of S$103.7 million by 5.1%.

  • NPI rose to S$78.4 million, which is 4.3% higher than forecasted.

  • DPU did even better at 3.499 Singapore cents, outperforming the forecast of 3.192 cents by 9.6%.

 
careit briefing8.26At CAREIT results briefing: CEO Tony Bin (centre) flanked by CFO Teo Chee Kiat (right) and Chief Investment Officer Ginny Ang.

 

If you had bought CAREIT units at its IPO price of S$0.88, this payout translates to an annualised dividend yield of 7.95%.

Even at the recent price of S$1.06 as of 30 June 2026, the annualised yield is 6.60%.

But the more interesting story is what comes next.


What Drove the Growth? 

A REIT grows by expanding its portfolio, and CAREIT has done exactly that.

Since its IPO, its total capacity has grown by 25.7% — expanding from 24,054 beds to 30,236 operational beds.

This growth was driven by:

  1. Singapore worker housing (PBWA): Added 4,360 beds across Westlite Toh Guan and Westlite Mandai.

  2. Student housing (PBSA) Expansion: In January 2026, CAREIT completed the A$345 million acquisition of EPIISOD Macquarie Park, a 732-bed student housing property in Sydney, Australia.

 

The headline PBWA financial occupancy of 92.2% initially looks slightly weak. But this is largely because thousands of newly licensed beds entered the denominator before they were fully occupied.

The better indicator is committed occupancy. By 31 July, Toh Guan had reached 99.0%, while Mandai was at 87.2%.

And there is another important point that emerged during the results briefing: rental reversions are running above the 3% assumed in the IPO prospectus. Management said increases have generally been above 3%, sometimes around 4% or a little higher.

Management expects 2H2026 gross revenue to exceed the prospectus forecast, helped by favourable PBWA rental rates, more occupied beds and around S$2.9 million of additional revenue from the Toh Guan and Mandai expanded capacity.


What Analysts Say? 


DBS analysts Ng Jia Hui and Derek Tan maintained"BUY" recommendation on CAREIT, with a target price of S$1.30 under review.

They called the performance a "strong set of results" that "beat estimates".

"We expect further earnings upside from the continued ramp-up of CAREIT's expansion projects. As at 31 July 2026, committed occupancy at Westlite Toh Guan and Westlite Mandai had reached 99.0% and 87.2% respectively, we expect further earnings upside as the remaining capacity is progressively filled."

Broker

Target price

DBS

S$1.30

CGS

S$1.39

CGS International analysts Li Jialin and Raymond Yap, similarly, expect a better future:

"We like its strong and visible DPU growth and potential for inorganic and organic opportunities. Re-rating catalysts: faster ramp-up of new capacity, and further capacity unlocking from existing assets." 

 

However, DBS also raised a note of caution regarding student housing in the UK:

"We remain watchful of the UK PBSA portfolio, where several headwinds have weighed on leasing momentum. As at end-July 2026, Manager's internal leasing records showed lower y/y pre-leasing for AY2026/27, which could temper occupancy and rental growth..." 

 

Safety First: A Prudent Balance Sheet 

 

High dividend yields are great, but only if they are sustainable.

Strong balance sheet
"CAREIT maintained a strong balance sheet, with aggregate leverage stood at 29.9%, a weighted average debt maturity of 3.7 years, and no refinancing requirements until FY2028."
-- DBS Research

CAREIT has so far kept its debt levels very low, with a gearing ratio of just 29.9%—well below the regulatory limit of 50%.

DBS noted this financial strength.
 

With S$380.0 million of debt headroom based on a 40% leverage limit, CAREIT has plenty of muscle to pursue new yield-accretive acquisitions in the future.

This matters because sponsor Centurion Corporation has a sizeable development pipeline that could eventually be injected into CAREIT.

The one area where the picture is less bullish is the UK PBSA portfolio, as DBS has noted.

Current occupancy remains excellent — 99.1% in the UK during 1H2026 — but pre-leasing for Academic Year 2026/27 was below the unusually strong levels of recent years.

Takeaway 

The attraction is no longer simply a high IPO yield.

There are now several identifiable earnings drivers: above-forecast PBWA rental reversions, the continuing Mandai ramp-up, additional revenue from newly licensed beds, and a sizeable acquisition pipeline.

Valuation-wise, however, CAREIT was already trading above its 87-cent NAV by the end of June.



→ See also:Bistro, Motel and Worker Quarters: CENTURION’s New Frontier in Australia's Pilbara

 





 

 

You may also be interested in:


 

We have 16738 guests and no members online

rss_2 NextInsight - Latest News